HIV pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV; however, PrEP
use among transgender individuals remains low. We conducted a systematic review to …

The purpose of this scoping review is to synthesize knowledge about medical mistrust and
health among women who occupy other marginalized identities; namely women who also …

Abstract Black and Hispanic/Latinx transgender women in the United States (US) are
disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) reduces risk of HIV …

Background Trans women are at increased risk for HIV infection yet are less likely to use pre-
exposure prophylaxis (PrEP) medication as a preventive measure. PrEP messaging and …

Background: TRIUMPH (Trans Research–Informed communities United in Mobilization for
the Prevention of HIV) was a community-led, transgender-specific pre-exposure prophylaxis …

This narrative review examines literature informing policy and laws relevant to the health
and well‐being of lesbian, gay, bisexual, transgender, and queer (LGBTQ+) adult …

Abstract Black and Hispanic/Latina transgender women are inequitably impacted by HIV; yet
gaps in PrEP use exist. Among a sample of mostly Black and Hispanic/Latina transgender …

Purpose Adherence to pre-exposure prophylaxis (PrEP) during periods of PrEP-indication
(ie, prevention-effective adherence) is critical for preventing HIV. We sought to describe …

Transgender persons face a greater burden of HIV compared to cisgender counterparts.
Concerns around drug–drug interactions (DDIs) have been cited as reasons for lower …

Purpose The purpose of this study was to develop pre-exposure prophylaxis (PrEP)
education materials that directly address the needs of trans women. PrEP medication is an …